Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of AIC090027 for HCMV prophylaxis after allogeneic HBPC transplantation
2009-013917-91Phase 2Completed
- Sponsor
- AiCuris
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AIC090027 in cytomegalovirus disease (CMV) (4 arms), sponsored by AiCuris. Primary endpoints: Incidence of HCMV prophylaxis failed and Time to onset of HCMV prophylaxis failed. Started Dec 2009; status: completed.
02
Drugs
AIC090027
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on 2009-013917-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013917-91.